Notify me when MPM BioImpact LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 40 | $610,879,430 | +$60,680,672 | -$109,010,583 | -$48,329,911 | MDGL, CGEM, RNA, TRVI, EWTX | 13F-HR | 14 Nov 2025, 16:30 |
| Q2 2025 | 44 | $577,150,843 | +$96,766,442 | -$109,400,259 | -$12,633,817 | CGEM, MDGL, ZLAB, GH, SPRY | 13F-HR | 14 Aug 2025, 16:45 |
| Q1 2025 | 43 | $581,677,555 | +$124,132,115 | -$131,904,699 | -$7,772,584 | CGEM, MDGL, ZLAB, EWTX, LNTH | 13F-HR | 15 May 2025, 16:45 |
| Q4 2024 | 47 | $704,362,373 | +$199,450,687 | -$70,469,706 | +$128,980,981 | CGEM, CRNX, EWTX, INSM, NTRA | 13F-HR | 14 Feb 2025, 16:20 |
| Q3 2024 | 43 | $666,570,839 | +$121,902,236 | -$113,688,535 | +$8,213,701 | CGEM, INSM, OLMA, RNA, CRNX | 13F-HR | 12 Nov 2024, 19:40 |
| Q2 2024 | 44 | $643,506,945 | +$157,959,921 | -$64,182,631 | +$93,777,290 | CGEM, INSM, OLMA, ITOS, CRNX | 13F-HR | 14 Aug 2024, 11:32 |
| Q1 2024 | 36 | $483,179,737 | +$161,395,990 | -$77,673,000 | +$83,722,990 | GERN, IOVA, ZNTL, ITOS, STRO | 13F-HR | 15 May 2024, 16:22 |
| Q4 2023 | 32 | $427,428,816 | +$25,421,555 | -$32,488,966 | -$7,067,411 | CGEM, IOVA, OLMA, GERN, ITOS | 13F-HR | 13 Feb 2024, 16:06 |
| Q3 2023 | 39 | $374,602,543 | +$58,621,803 | -$121,103,279 | -$62,481,476 | CGEM, OLMA, GERN, RPTX, ITOS | 13F-HR | 14 Nov 2023, 16:38 |
| Q2 2023 | 41 | $496,602,631 | +$138,075,140 | -$67,708,607 | +$70,366,533 | CGEM, ISEE, KDNY, GERN, RETA | 13F-HR | 14 Aug 2023, 12:19 |
| Q1 2023 | 31 | $384,916,993 | +$43,120,354 | -$16,534,597 | +$26,585,757 | CGEM, PRVB, ISEE, ITOS, INBX | 13F-HR | 12 May 2023, 13:02 |
| Q4 2022 | 33 | $385,456,912 | +$49,520,591 | -$6,963,043 | +$42,557,548 | CGEM, ITOS, INBX, RPTX, ISEE | 13F-HR | 14 Feb 2023, 11:41 |
| Q3 2022 | 38 | $422,223,000 | +$74,289,939 | -$6,261,278 | +$68,028,661 | CGEM, ITOS, INBX, VERV, NTLA | 13F-HR | 14 Nov 2022, 09:22 |
| Q2 2022 | 37 | $359,998,000 | +$43,008,021 | -$1,178,712 | +$41,829,309 | CGEM, ITOS, RPTX, MRUS, NTLA | 13F-HR | 11 Aug 2022, 17:27 |
| Q1 2022 | 37 | $372,610,000 | +$23,531,315 | -$5,713,485 | +$17,817,830 | CGEM, ITOS, MRUS, RPTX, HARPXXXX | 13F-HR | 13 May 2022, 12:05 |
| Q4 2021 | 33 | $548,527,000 | +$39,123,419 | -$19,569,060 | +$19,554,359 | CGEM, ITOS, RPTX, MEIPXXXX, MRUS | 13F-HR | 11 Feb 2022, 15:37 |
| Q3 2021 | 33 | $644,676,000 | +$155,338,310 | -$13,196,043 | +$142,142,267 | CGEM, ITOS, RPTX, HOWL, TCRR | 13F-HR | 12 Nov 2021, 18:19 |
| Q2 2021 | 14 | $608,714,000 | +$41,646,912 | -$24,965,603 | +$16,681,309 | CGEM, ITOS, TCRR, RPTX, HARPXXXX | 13F-HR | 13 Aug 2021, 09:24 |
| Q1 2021 | 13 | $795,909,000 | +$329,771,671 | -$33,653,405 | +$296,118,266 | CGEM, HARPXXXX, ITOS, TCRR, RPTX | 13F-HR | 13 May 2021, 15:46 |
| Q4 2020 | 13 | $569,376,000 | +$76,848,937 | -$5,681,880 | +$71,167,057 | TCRR, RPTX, ITOS, ONCR, HARPXXXX | 13F-HR/A | 24 Feb 2021, 15:55 |
| Q4 2020 | 1 | $26,764 | $0 | 13F-HR | 16 Feb 2021, 05:45 | |||
| Q3 2020 | 12 | $415,058,000 | $0 | RPTX, TCRR, HARPXXXX, ITOS, EPZM | Restatement | 19 Nov 2020, 13:36 | ||
| Q2 2020 | 1 | $41,869 | $0 | 13F-HR | 12 Aug 2020, 12:12 | |||
| Q1 2020 | 10 | $163,704,000 | +$13,786,009 | +$13,786,009 | HARPXXXX, EPZM, TCRR, GTHX, TPTX | 13F-HR | 13 May 2020, 12:16 | |
| Q4 2019 | 12 | $282,172,000 | $0 | HARPXXXX, EPZM, TCRR, GTHX, ARQL | 13F-HR | 14 Feb 2020, 14:03 |